Glatiramer acetate slows disability progression - results from a 6-year analysis of the UK Risk Sharing Scheme
800 - 801
MetadataShow full item record
The UK Multiple Sclerosis Risk Sharing Scheme (RSS) was established in 2002 following a National Institute for Health and Care Excellence (NICE) appraisal of the disease‐modifying therapies (DMTs) glatiramer acetate (GA) and the beta interferons...
AuthorsGiovannoni, G; Brex, P; Sumra, M; Walters, E; Schmierer, K
- College Publications